🔎 Trials Near Me

Home › Blood Cancers › South Carolina

Blood Cancers clinical trials in South Carolina

8 studies for Blood Cancers are looking for participants at sites in South Carolina.

Cities in South Carolina

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • AnMed Health Cancer Center, Anderson
  • Prisma Health Richland Hospital, Columbia
  • McLeod Regional Medical Center, Florence
  • and 12 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • Saint Francis Hospital, Greenville
  • Saint Francis Cancer Center, Greenville
RecruitingObservational study
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • MUSC Health University Medical Center, Charleston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • Bon Secours St. Francis Cancer Center, Greenville
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT04588922

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • Prisma Health, Greenville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788

A Phase 1/2 Study of KK2430 in Participants With Hematologic Neoplasms

  • Prisma Health, Greenville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT07629726

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Medical University of South Carolina, Charleston
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

  • Medical University of South Carolina, Charleston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT02074839

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.